Appeals court overturns a Monsanto win on Roundup cancer issue
A federal appeals court has rejected a bid by Monsanto owner Bayer AG to head off claims brought by cancer victims alleging that Monsanto failed to warn them of the risks of Roundup.
A federal appeals court has rejected a bid by Monsanto owner Bayer AG to head off claims brought by cancer victims alleging that Monsanto failed to warn them of the risks of Roundup.
Building on years of research that shows links between agricultural chemicals and cancer, researchers say they have found fresh evidence tying certain pesticides to cancers in children and adults in 11 western U.S. states.
Earlier this month, a court decision about a chemical called glyphosate garnered headlines in newspapers across the country. And rightly so: glyphosate is the active ingredient in Monsanto’s Roundup weedkiller.
A Kansas City, Mo., jury on Thursday dismissed claims by a man who blamed his cancer on exposure to Monsanto’s Roundup herbicide, agreeing with the company that the weed killer was not the source of the man’s disease.
Former Monsanto chief Hugh Grant spent several hours on the witness stand on Tuesday – testifying for the first time in front of a jury at a Roundup trial – telling the court repeatedly that global regulators had found no evidence that the company’s herbicides cause cancer.
The U.S. Solicitor General on Tuesday dealt a blow to Monsanto owner Bayer AG, advising the U.S. Supreme Court that it should deny the company’s request for a review of a key Roundup cancer trial loss.
By Judy Wu-Smart
It has been approximately five years since I began finding total losses of the honey bee colonies located on a University research and extension center near Mead, Nebraska, where I keep bees and work as a scientist studying pesticides and bee decline. And it’s been more than two years since I began to suspect something terribly wrong was happening around the university research station.
Three people suffering from cancer are set to face off against Monsanto in the latest courtroom battle over allegations that exposure to the company’s Roundup weed killer causes non-Hodgkin lymphoma.